Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy

Surgery (United States)

Volumn 159, Issue 3, 2016, Pages 893-900

  Christians, Kathleen K ^a   Heimler, Jonathan W ^a   George, Ben ^a   Ritch, Paul S ^a   Erickson, Beth A ^a   Johnston, Fabian ^a   Tolat, Parag P ^a   Foley, William D ^a   Evans, Douglas B ^a   Tsai, Susan ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; CISPLATIN; ERLOTINIB; GEMCITABINE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FUNCTIONAL STATUS; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEOADJUVANT THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS RESECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TUMOR INVASION;

AGED; CAUSE OF DEATH; CHEMORADIOTHERAPY; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 84950987094     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.09.018     Document Type: Article

References (31)

1. M.P. Callery, K.J. Chang, E.K. Fishman, and et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol 16 2009 1727 1733
2. D.B. Evans, M.D. Farnell, K.D. Lillemoe, and et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 2009 1736 1744
3. National Comprehensive Cancer Network. NCCN practice guidelines for pancreatic cancer, version 2. Available from: http://www.nccn.org/professionals/physician-gls/recently-updated.asp.
4. B.L. Appel, P. Tolat, D.B. Evans, and S. Tsai Current Staging System for Pancreatic Cancer Cancer J 18 2012 539 549
5. A. Bittoni, M. Santoni, A. Lanese, and et al. Neoadjuvant therapy in pancreatic cancer: an emerging strategy Gastroenterol Res Pract 183 2014 85 93
6. J.M. Sutton, and D.E. Abbott Neoadjuvant therapy for pancreas cancer: past lessons and future therapies World J Gastroenterol 20 2014 15564 15579
7. K.K. Christians, S. Tsai, P.P. Tolat, and D.B. Evans Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma J Surg Oncol 107 2013 33 38
8. D.B. Evans, K.C. Christians, and W.D. Foley Pancreaticoduodenectomy (Whipple Operation) and total pancreatectomy for cancer J.L. Fischer, Mastery of surgery 6th ed. 2012 Wolters Kluwer/Lippincott Williams & Wilkins Philadelphia 1445 1466
9. K.K. Christians, K. Riggle, R. Keim, S. Pappas, S. Tsai, P. Ritch, and et al. Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: initial experience from the Medical College of Wisconsin Surgery 154 2013 123 131
10. S.B. Edge, D.R. Byrd, C.C. Compton, and et al. AJCC cancer staging manual 7th ed. 2010 Springer New York
11. J.M. Winter, M.F. Brennan, L.H. Tang, and et al. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades Ann Surg Oncol 19 2012 169 175
12. J.M. Winter, J.L. Cameron, K.A. Campbell, M.A. Arnold, D.C. Chang, J. Coleman, and et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience J Gastrointest Surg 10 2006 1199 1210 discussion 210-1
13. R.A. Wolff, C.H. Crane, D. Li, and D.B. Evans Neoplasms of the exocrine pancreas W.K. Hong, R.C. Bast, W.N. Hait, D.W. Kufe, R.E. Pollock, R.R. Weichelbaum, Holland-Frei Cancer Medicine 8th ed. 2010 B.C. Decker, Inc Shelton (CT) 1144 1171
14. K.Y. Bilimoria, D.J. Bentrem, C.Y. Ko, and et al. Multimodality therapy for pancreatic cancer in the U.S: utilization, outcomes, and the effect of hospital volume Cancer 110 2007 1227 1234
15. M.M. Corsini, R.C. Miller, M.G. Haddock, and et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005) J Clin Oncol 26 2008 3511 3516
16. T.A. Aloia, J.E. Lee, J.N. Vauthey, and et al. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy J Am Coll Surg 204 2007 347 355
17. C.W. Tzeng, H.S. Tran Cao, J.E. Lee, and et al. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival J Gastrointest Surg 18 2014 16 24
18. D.K. Chang, A.L. Johns, and N.D. Merrett Margin clearance and outcome in resected pancreas cancer J Clin Oncol 27 2009 2855 2862
19. C.P. Raut, J.F. Tseng, C.C. Sun, and et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 2007 52 60
20. H. Oettle, P. Neuhaus, A. Hochhaus, and et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreas cancer: the CONKO-001 randomized trial JAMA 310 2013 1473 1481
21. D.B. Evans, G.R. Varadhachary, C.H. Crane, and et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 2008 3496 3502
22. G.R. Varadhachary, R.A. Wolff, C.H. Crane, and et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 2008 3487 3495
23. D.B. Evans, T.A. Rich, D.R. Byrd, and et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 1992 1335 1339
24. M.V. Pilepich, and H.H. Miller Preoperative irradiation in carcinoma of the pancreas Cancer 46 1980 1945 1949
25. J.P. Neoptolemos, D.D. Stocken, H. Friess, and et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
26. C.L. Roland, A.D. Yang, M.H. Katz, and et al. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer Ann Surg Oncol 22 2015 1168 1175
27. J.L. Cameron, T.S. Riall, J. Coleman, and et al. One thousand consecutive pancreaticoduodenectomies Ann Surg 244 2006 10 15
28. M. Aldakkak, K.K. Christians, A.N. Krepline, B. George, P.S. Ritch, B.A. Erickson, and et al. Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer HPB (Oxford) 17 2015 942 952
29. D. Chatterjee, M. Katz, A. Rashid, and et al. Pancreatic intraepithelial neoplasia and histological changes in the non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma Histopathology 63 2013 841 851
30. S.W. Cho, C.W. Tzeng, W.C. Johnston, and et al. Neoadjuvant radiation therapy and its impact on complications after pancreatiduodenectomy for pancreatic cancer: analysis of the ACS-NSQIP HPB (Oxford) 16 2014 350 356
31. H. Takahashi, J. Ogawa, H. Ohigashi, and et al. Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma Surgery 150 2011 547 556